Merck & Co. is enjoying a spurt of new drug launches, partly due to its $41 billion November acquisition of New Jersey neighbor Schering-Plough Corp. Some have been on the market in the United States for a while, including blockbuster diabetes medicine Januvia, and are now being launched in other countries.

  

Drug Name	Condition/Use	Where It’s Launching
Asmanex	Asthma?	Japan
Bridion	Reversal of?anesthesia	30?countries?outside?the?U.S.
Elonva	Fertility?treatment	European?Union
Januvia	Type?2?diabetes	Japan
Remeron	Depression	Japan
Saflutan	Glaucoma	European?Union
Saphris	Schizophrenia/bipolar?disorder	United?States
Simponi	Immune?disorders	5?countries
Tredaptive	Hardening?of?the?arteries	27?countries?outside?the?U.S.